The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Organometallic Anticancer Compounds
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTOrganometallic Anticancer CompoundsGilles Gasser*†§, Ingo Ott*‡, and Nils Metzler-Nolte*§View Author Information† Institute of Inorganic Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland‡ Institute of Pharmaceutical Chemistry, Technische Universität Braunschweig, Beethovenstrasse 55, 38106 Braunschweig, Germany§ Chair of Inorganic Chemistry I, Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Universitätsstrasse 150, 44801 Bochum, Germany*To whom correspondence should be addressed. For G.G.: phone, +41(0)44 635-4611; fax, +41(0)44 635-6803; e-mail, [email protected]; Web page, www.gassergroup.com. For I.O.: phone, +49 (0)531-391 2743; fax, +49 (0)531-391 8456; e-mail, [email protected]; Web page, www.pharmchem.tu-bs.de/forschung/ott/. For N.M.-N.: phone, +49 (0)234-32 28152; fax, +49 (0)234-32 14378; e-mail, [email protected]; Web page, www.chemie.rub.de/ac1.Cite this: J. Med. Chem. 2011, 54, 1, 3–25Publication Date (Web):November 15, 2010Publication History Received8 January 2010Published online15 November 2010Published inissue 13 January 2011https://doi.org/10.1021/jm100020wCopyright © 2010 American Chemical SocietyRIGHTS & PERMISSIONSACS AuthorChoiceArticle Views34024Altmetric-Citations1313LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (3 MB) Get e-AlertscloseSUBJECTS:Genetics,Ligands,Metals,Reaction products,Sandwich compounds Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Antitumour metal compounds: more than theme and variations
Jakupec, M. A., Galanski, M. S., Arion, V. B., Hartinger, C. G., & Keppler, B. K. (2008) · Dalton Transactions · doi:10.1039/b712656p · Cited by 850
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Self-citationIn Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Scolaro, C., Bergamo, A., Brescacín, L., Delfino, R., Cocchietto, M., Laurenczy, G., Geldbach, T. J., Sava, G., & Dyson, P. J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050015d · Cited by 784
Metal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
Ray, S., Mohan, R., Singh, J. K., Samantaray, M. K., Shaikh, M. M., Panda, D., & Ghosh, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075889z · Cited by 656
Areneruthenium complexes as anticancer agents
Süß‐Fink, G. (2009) · Dalton Transactions · doi:10.1039/b916860p · Cited by 652
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Bindoli, A., Rigobello, M. P., Scutari, G., Gabbiani, C., Casini, A., & Messori, L. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.026 · Cited by 595
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Melaiye, A., Sun, Z., Hindi, K., Milsted, A., Ely, D., Reneker, D. H., Tessier, C. A., & Youngs, W. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja040226s · Cited by 557
Non-platinum group metal antitumor agents. History, current status, and perspectives
Koepf-Maier, P., & Koepf, H. (1987) · Chemical Reviews · doi:10.1021/cr00081a012 · Cited by 509
Allardyce, C. S., Dyson, P. J., Ellis, D. J., & Heath, S. L. (2001) · Chemical Communications · doi:10.1039/b104021a · Cited by 495
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
Targeting proteins with metal complexes
Meggers, E. (2009) · Chemical Communications · doi:10.1039/b813568a · Cited by 450
Therrien, B., Süss‐Fink, G., Govindaswamy, P., Renfrew, A. K., & Dyson, P. J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800186 · Cited by 446
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Formation of Water-Soluble Pincer Silver(I)−Carbene Complexes: A Novel Antimicrobial Agent
Melaiye, A., Simons, R. S., Milsted, A., Pingitore, F., Wesdemiotis, C., Tessier, C. A., & Youngs, W. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030262m · Cited by 349
A categorization of metal anticancer compounds based on their mode of action
Gianferrara, T., Bratsos, I., & Alessio, E. (2009) · Dalton Transactions · doi:10.1039/b905798f · Cited by 336
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
Metal Ions in Biological Systems: Volume 29: Biological Properties of Metal Alkyl Derivatives
Sigel, H., & Sigel, A. (2024) · CRC Press eBooks · doi:10.1201/9781003573890 · Cited by 288
Exploring biologically relevant chemical space with metal complexes
Meggers, E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.013 · Cited by 274
Casini, A., Gabbiani, C., Sorrentino, F., Rigobello, M. P., Bindoli, A., Geldbach, T. J., Marrone, A., Re, N., Hartinger, C. G., Dyson, P. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006678 · Cited by 270
Niesel, J., Pinto, A., Peindy N'Dongo, H. W., Merz, K., Ott, I., Gust, R., & Schatzschneider, U. (2008) · Chemical Communications · doi:10.1039/b719075a · Cited by 267
Self-citationOn the mechanism of the antitumor activity of ferrocenium derivatives
Osella, D., Ferrali, M., Zanello, P., Laschi, F., Fontani, M., Nervi, C., & Cavigiolio, G. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)00147-x · Cited by 266
Metal Carbonyls: A New Class of Pharmaceuticals?
Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J., & Motterlini, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200301634 · Cited by 261
Cationic iridium(iii) complexes for phosphorescence staining in the cytoplasm of living cells
Yu, M., Zhao, Q., Shi, L., Li, F., Zhou, Z., Yang, H., Yi, T., & Huang, C. (2008) · Chemical Communications · doi:10.1039/b800939b · Cited by 255
Wang, F., Chen, H., Parsons, S., Oswald, I. D. H., Davidson, J. E., & Sadler, P. J. (2003) · Chemistry – A European Journal · doi:10.1002/chem.200304724 · Cited by 254
Antitumour Metallocenes: Structure-Activity Studies and Interactions with Biomolecules.
Harding, M., & Mokdsi, G. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374066 · Cited by 233
Hindi, K. M., Siciliano, T. J., Durmus, S., Panzner, M. J., Medvetz, D. A., Reddy, D. V., Hogue, L. A., Hovis, C. E., Hilliard, J. K., Mallet, R. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0708679 · Cited by 218
Hillard, E. A., de Abreu, F. C., Ferreira, D. C. M., Jaouen, G., Goulart, M. O. F., & Amatore, C. (2008) · Chemical Communications · doi:10.1039/b718116g · Cited by 216
Ott, I., Schmidt, K., Kircher, B., Schumacher, P., Wiglenda, T., & Gust, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049326z · Cited by 207
Self-citationVessières, A., Top, S., Pigeon, P., Hillard, E., Boubeker, L., Spera, D., & Jaouen, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050251o · Cited by 206
Dorcier, A., Ang, W. H., Bolaño, S., Gonsalvi, L., Juillerat-Jeannerat, L., Laurenczy, G., Peruzzini, M., Phillips, A. D., Zanobini, F., & Dyson, P. J. (2006) · Organometallics · doi:10.1021/om060394o · Cited by 203
The Design of Organometallic Ruthenium Arene Anticancer Agents
Dougan, S. J., & Sadler, P. J. (2007) · CHIMIA · doi:10.2533/chimia.2007.704 · Cited by 202
New Principles in Medicinal Organometallic Chemistry
Schatzschneider, U., & Metzler‐Nolte, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504604 · Cited by 194
Self-citationBiot, C., Taramelli, D., Forfar-Bares, I., Maciejewski, L. A., Boyce, M., Nowogrocki, G., Brocard, J. S., Basilico, N., Olliaro, P., & Egan, T. J. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500061 · Cited by 192
Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms
Vock, C. A., Ang, W. H., Scolaro, C., Phillips, A. D., Lagopoulos, L., Juillerat-Jeanneret, L., Sava, G., Scopelliti, R., & Dyson, P. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070039f · Cited by 185
Mendoza-Ferri, M. G., Hartinger, C. G., Mendoza, M. A., Groessl, M., Egger, A. E., Eichinger, R. E., Mangrum, J. B., Farrell, N. P., Maruszak, M., Bednarski, P. J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013234 · Cited by 185
Rational Design of an Organometallic Glutathione Transferase Inhibitor
Ang, W. H., Parker, L. J., De Luca, A., Juillerat‐Jeanneret, L., Morton, C. J., Lo Bello, M., Parker, M. W., & Dyson, P. J. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900185 · Cited by 182
Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes
Alberto, R., & Motterlini, R. (2007) · Dalton Transactions · doi:10.1039/b701992k · Cited by 182
Small Molecules as Inhibitors of Cyclin‐Dependent Kinases
Huwe, A., Mazitschek, R., & Giannis, A. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200540 · Cited by 181
Vessières, A., Top, S., Beck, W., Hillard, E., & Jaouen, G. (2006) · Dalton Trans. · doi:10.1039/b509984f · Cited by 180
Macromolecular Ferrocene Compounds as Cancer Drug Models
Neuse, E. W. (2005) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-004-2371-9 · Cited by 177
Schäfer, S., Ott, I., Gust, R., & Sheldrick, W. S. (2007) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200700206 · Cited by 175
Self-citationLau, J. S.-Y., Lee, P.-K., Tsang, K. H.-K., Ng, C. H.-C., Lam, Y.-W., Cheng, S.-H., & Lo, K. K.-W. (2009) · Inorganic Chemistry · doi:10.1021/ic801818x · Cited by 174
Wang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Iridium Complex with Antiangiogenic Properties
Wilbuer, A., Vlecken, D. H., Schmitz, D. J., Kräling, K., Harms, K., Bagowski, C. P., & Meggers, E. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000682 · Cited by 168
Anti-proliferative activity and mechanism of action of titanocene dichloride
Christodoulou, C., Eliopoulos, A. G., Young, L. S., Hodgkins, L., Ferry, D. R., & Kerr, D. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.352 · Cited by 145
Auzias, M. G., Therrien, B., Süß‐Fink, G., Štěpnička, P., Ang, W. H., & Dyson, P. J. (2007) · Inorganic Chemistry · doi:10.1021/ic7018742 · Cited by 144
Nováková, O., Kašpárková, J., Bursová, V., Hofr, C., Vojtíšková, M., Chen, H., Sadler, P. J., & Brabec, V. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.008 · Cited by 136
Allard-Vannier, É., Passirani, C., Garcion, E., Pigeon, P., Vessières, A., Jaouen, G., & Benoît, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.027 · Cited by 132
Novel benzyl substituted titanocene anti-cancer drugs
Sweeney, N. J., Mendoza, Ó., Müller‐Bunz, H., Pampillón, C., Rehmann, F. K., Strohfeldt, K. A., & Tacke, M. (2005) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2005.06.039 · Cited by 129
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
Organometallic Ruthenium Inhibitors of Glutathione‐S‐Transferase P1‐1 as Anticancer Drugs
Ang, W. H., Luca, A. D., Chapuis‐Bernasconi, C., Juillerat‐Jeanneret, L., Bello, M. L., & Dyson, P. J. (2007) · ChemMedChem · doi:10.1002/cmdc.200700209 · Cited by 126
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers
Chen, H., Parkinson, J. A., Nováková, O., Bella, J., Wang, F., Dawson, A., Gould, R. O., Parsons, S., Brabec, V., & Sadler, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434016100 · Cited by 125
A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents
Hillard, E. A., Vessières, A., Bideau, F. L., Plażuk, D., Spera, D., Huché, M., & Jaouen, G. (2006) · ChemMedChem · doi:10.1002/cmdc.200500035 · Cited by 120
Ruthenium(II) Arene Anticancer Complexes with Redox-Active Diamine Ligands
Bugarcic, T., Habtemariam, A., Deeth, R. J., Fabbiani, F. P. A., Parsons, S., & Sadler, P. J. (2009) · Inorganic Chemistry · doi:10.1021/ic9013366 · Cited by 117
Organometallic Osmium(II) Arene Anticancer Complexes Containing Picolinate Derivatives
van Rijt, S., Peacock, A. F. A., Johnstone, R. D. L., Parsons, S., & Sadler, P. J. (2009) · Inorganic Chemistry · doi:10.1021/ic8020222 · Cited by 112
Louie, M., Liu, H.-W., Lam, M. H., Lau, T., & Lo, K. K. (2009) · Organometallics · doi:10.1021/om900311s · Cited by 111
Payen, O., Top, S., Vessières, A., Brûlé, E., Plamont, M., McGlinchey, M. J., Müller‐Bunz, H., & Jaouen, G. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701264d · Cited by 103
Deubel, D. V., & Lau, J. K. (2006) · Chemical Communications · doi:10.1039/b601590e · Cited by 92
Zhang, W., Atkin, A. J., Thatcher, R. J., Whitwood, A. C., Fairlamb, I. J. S., & Lynam, J. M. (2009) · Dalton Transactions · doi:10.1039/b822157j · Cited by 87
Atkin, A. J., Williams, S., Sawle, P., Motterlini, R., Lynam, J. M., & Fairlamb, I. J. S. (2009) · Dalton Transactions · doi:10.1039/b904627p · Cited by 83
Guo, M., Guo, Z., & Sadler, P. J. (2001) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100248 · Cited by 82
Buriez, O., Heldt, J., Labbé, É., Vessières, A., Jaouen, G., & Amatore, C. A. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800507 · Cited by 82
Iron‐Containing Nucleoside Analogues with Pronounced Apoptosis‐Inducing Activity
Schlawe, D., Majdalani, A., Velcicky, J., Heßler, E., Wieder, T., Prokop, A., & Schmalz, H. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353132 · Cited by 81
Intracellular mapping of the distribution of metals derived from the antitumor metallocenes
Waern, J. B., Harris, H. H., Lai, B. C. H., Cai, Z., Harding, M. M., & Dillon, C. T. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0649-1 · Cited by 80
Anand, R., Maksimoska, J., Pagano, N., Wong, E., Gimotty, P. A., Diamond, S. L., Meggers, E., & Marmorstein, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8005806 · Cited by 78
Synthesis and Structure Activity Relationship of Organometallic Steroidal Androgen Derivatives
Top, S., Thibaudeau, C., Vessières, A., Brûlé, E., Bideau, F. L., Joerger, J., Plamont, M., Samreth, S., Edgar, A., Marrot, J., et al. (2009) · Organometallics · doi:10.1021/om800698y · Cited by 76
Jellicoe, M. M., Nichols, S. J., Callus, B. A., Baker, M. V., Barnard, P. J., Berners‐Price, S. J., Whelan, J., Yeoh, G. C., & Filipovska, A. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn093 · Cited by 75
O’Connor, K. M., Gill, C., Tacke, M., Rehmann, F.-J. K., Strohfeldt, K. A., Sweeney, N. J., Fitzpatrick, J. M., & Watson, R. W. G. (2006) · APOPTOSIS · doi:10.1007/s10495-006-6796-1 · Cited by 71
Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment
Anh, N. T. V., Marsaud, V., Bouclier, C., Top, S., Vessières, A., Pigeon, P., Gref, R., Legrand, P., Jaouen, G., & Renoir, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.033 · Cited by 71
Top, S., Vessières, A., Pigeon, P., Rager, M., Huché, M., Salomon, E., Cabestaing, C., Vaissermann, J., & Jaouen, G. (2004) · ChemBioChem · doi:10.1002/cbic.200400067 · Cited by 70
Top, S., Kaloun, E. B., Vessières, A., Laïos, I., Leclercq, G., & Jaouen, G. (2002) · Journal of Organometallic Chemistry · doi:10.1016/s0022-328x(01)01271-2 · Cited by 67
Medicinal Organometallic Chemistry
Jaouen, G., & Dyson, P. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045047-4/00173-4 · Cited by 62
Design of nickel chelates of tetradentate N-heterocyclic carbenes with subdued cytotoxicity
Ray, S., Asthana, J., Tanski, J. M., Shaikh, M. M., Panda, D., & Ghosh, P. (2009) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2009.03.036 · Cited by 61
Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model
Allard-Vannier, É., Huynh, N. T., Vessières, A., Pigeon, P., Jaouen, G., Benoît, J., & Passirani, C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.031 · Cited by 58
Franke, J. C., Plötz, M., Prokop, A., Geilen, C. C., Schmalz, H., & Eberle, J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.022 · Cited by 55
Bannon, J. H., Fichtner, I., O'Neill, A., Pampillón, C., Sweeney, N. J., Strohfeldt, K. A., Watson, R. W. G., Tacke, M., & Gee, M. M. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604021 · Cited by 54
Kim, J. H., Kim, J. H., Lee, G. E., Kim, S. W., & Chung, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 54
Ott, I., Koch, T., Shorafa, H., Bai, Z., Poeckel, D., Steinhilber, D., & Gust, R. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b504294c · Cited by 52
Self-citationZekri, O., Hillard, E. A., Top, S., Vessières, A., Pigeon, P., Plamont, M., Huché, M., Boutamine, S., McGlinchey, M. J., Müller-Bunz, H., et al. (2009) · Dalton Transactions · doi:10.1039/b819812h · Cited by 32
Wang, F., Weidt, S. K., Xu, J., Mackay, C. L., Langridge‐Smith, P. R. R., & Sadler, P. J. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.12.002 · Cited by 30
Salmain, M., Vessières, A., Brossier, P., & Jaouen, G. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1015 · Cited by 23
Cited by
Metallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Organoiridium Complexes: Anticancer Agents and Catalysts
Liu, Z., & Sadler, P. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar400266c · Cited by 573
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Self-citation
Metadata
- Authors
- Gasser, G., Ott, I., & Metzler-Nolte, N.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-11-15
- Volume
- 54
- Issue
- 1
- Pages
- 3-25
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2017356685
- Cited by
- 1,624
- References
- 90
- FWCI
- 42.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.